U.S. Healthcare Services Stock News

Erasca (NasdaqGS:ERAS) entered a collaboration with Merck to study ERAS-0015 in combination with KEYTRUDA in RAS mutant solid tumors. The companies agreed a new clinical trial arrangement that will evaluate the combination regimen in late-stage settings. Erasca focuses on therapies that target the RAS pathway, an area of high interest across oncology research. KEYTRUDA is a widely used immuno-oncology therapy, so pairing it with ERAS-0015 places the company in a clinically and commercially...

Willdan Group, Inc. recently reported first-quarter 2026 results, with sales of US$155.11 million and net income of US$8.53 million, alongside higher earnings per share than a year earlier. The company linked its improved quarterly performance to strong demand for its energy solutions and benefits from the Burton Energy Group acquisition, while also raising its 2026 financial targets and long-term margin goals. Next, we will examine how Willdan’s upgraded 2026 financial targets and margin...

Wondering whether CoStar Group at around US$34.01 is starting to look like value or still has more room to fall or recover? This article breaks down what the current price might be implying about the stock. The stock has risen 6.4% over the last week, yet it remains down 15.1% over the last month and has declined 48.2% year to date and 54.0% over the past year, so recent trading has been choppy for long term holders. Recent coverage around CoStar Group has focused on how investors are...

If you are wondering whether Caledonia Mining stock is offering value at around US$22.96, it helps to line up the recent share price moves with what the business might be worth. The stock has pulled back recently, with the price declining about 7.2% over the past week and 12.2% over the past month, although the 1 year return of 35.9% and 3 year return of 100.4% paint a very different picture for longer term holders. Recent moves in the share price sit against a backdrop of ongoing interest...

Immunovant (IMVT) is back in focus after Week 16 data for its IMVT-1402 rheumatoid arthritis trial showed strong response rates in difficult cases, and its latest earnings report highlighted ongoing losses and funding for continued development. See our latest analysis for Immunovant. The latest IMVT-1402 update has shifted attention firmly to Immunovant’s pipeline, with a 1-day share price return of 35.26% helping push the stock to a 1-year total shareholder return of 144.23%, signaling...

Redwire (NYSE:RDW) has secured a high eight-figure, multi-year contract from a NATO ally for its Penguin Mk3 tactical uncrewed aerial system. The award covers next-generation Penguin Mk3 drone systems and long-term program support using Redwire's European infrastructure. The Penguin platform has operational experience in Ukraine, which supported the selection decision for this NATO contract. For you as an investor, this NATO order adds a concrete defense program to Redwire's existing space...

Wondering whether Vertiv Holdings Co at around US$315.67 is still offering value after its big run, or if you might be late to the story. The stock has been volatile recently, with a decline of 14.7% over the last 7 days, a small 0.4% gain over 30 days, and much stronger returns of 79.8% year to date and 205.0% over the past year. Recent coverage has focused on Vertiv's role in supporting power and cooling infrastructure for data centers and AI related demand, along with investor interest in...

Stanley Black & Decker (NYSE:SWK) has renewed and expanded its BLACK+DECKER toy licensing agreement with JAKKS Pacific. The multi year deal extends the partnership through 2028 across key North and South American markets. The agreement covers a broad range of toy product categories aimed at younger consumers. For a tools and hardware company such as Stanley Black & Decker, the BLACK+DECKER toy line is one way to keep the brand in front of future do it yourself customers. The renewed JAKKS...

Stock performance snapshot Bristol-Myers Squibb (BMY) has drawn fresh attention after a solid year-to-date total return of about 9.5%, alongside a 1-year total return near 30.8% and a current share price around US$58.54. See our latest analysis for Bristol-Myers Squibb. Recent moves show mixed momentum, with the 7-day share price return of 3.8% sitting against a 30-day share price decline of 1.0%. However, the 1-year total shareholder return of 30.8% points to a stronger longer term...

Recent share performance context Cummins (CMI) has drawn fresh attention after a period where the stock is up around 5% over the past month and roughly 12% in the past 3 months, which contrasts with its 7 day pullback. See our latest analysis for Cummins. That recent 7 day share price pullback of 5.59% comes after a stronger run, with the year to date share price return at 28.32% and the 1 year total shareholder return at 111.11%. This suggests that momentum has recently cooled following a...

Kanzhun Limited has now reported its first-quarter 2026 results, with revenue rising to CNY 2,068.79 million and net income to CNY 1,156.69 million, alongside higher basic and diluted earnings per share. Beyond the headline figures, management pointed to rapid AI adoption and growth in paid enterprise customers and blue-collar recruitment as key drivers of the quarter’s performance. We’ll now examine how Kanzhun’s stronger profitability, supported by AI-driven recruitment and ongoing share...

T1 Energy Inc. reported past first-quarter 2026 results showing revenue rising to US$177.65 million from US$53.45 million a year earlier, while the company remained loss-making and maintained its 2026 production guidance of 3.1–4.2 GW. Investor attention has intensified as institutional ownership increased, short-seller allegations raised questions about regulatory compliance, and management pushed ahead with funding and construction plans for its G2_Austin facility. We’ll now examine how T1...

Before you decide whether Oracle stock looks attractively priced or stretched, it helps to line up the recent share performance with what the current valuation actually reflects. Oracle shares recently closed at US$188.16, with the price slipping 0.8% over the past week, rising 6.0% over the last 30 days, declining 3.9% year to date, and up 20.9% over the past year, alongside very large gains of 98.3% over three years and 154.0% over five years. Recent headlines around Oracle have kept the...

Zeta Global Holdings (ZETA) is back in the spotlight after reporting 50% year over year revenue growth in the first quarter of 2026, raising its full year outlook, and deepening partnerships with Snowflake and OpenAI. See our latest analysis for Zeta Global Holdings. The recent partnership announcements and Q1 results have shifted sentiment, with a 14.34% 7 day share price return and 16.96% 90 day share price return. This contrasts with a share price that is still down 7.89% year to date,...

Galaxy Digital secured a BitLicense and Money Transmission License in New York, allowing it to offer regulated digital asset services in the state. The approvals open the door to institutional clients in New York, including registered investment advisors, hedge funds, and family offices. The move expands Galaxy Digital's regulated platform beyond previously covered fund launches or filings. Galaxy Digital (NasdaqGS:GLXY) is pushing deeper into regulated markets with these New York...

Some Super Group (SGHC) Limited ( NYSE:SGHC ) shareholders may be a little concerned to see that the Chief of Staff...

Over the last 7 days, the United States market has remained flat, yet it has experienced a significant 27% rise over the past year. In this context of anticipated earnings growth at 17% per annum in the coming years, identifying small-cap stocks with insider activity can be an intriguing strategy for investors seeking potential opportunities amidst these dynamic market conditions.

In the last week, the United States market has stayed flat, yet it is up 27% over the past year with earnings forecasted to grow by 17% annually. In such an environment, identifying potentially undervalued stocks like Fifth Third Bancorp can offer investors opportunities for growth at a reasonable price.

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...

The United States market remained flat over the last week but has shown a 27% rise over the past 12 months, with earnings expected to grow by 17% annually in the coming years. In this context, growth companies with high insider ownership can be particularly appealing as they often indicate strong confidence from those who know the business best.

The United States market has shown notable resilience, with a 27% increase over the past year and a forecasted annual earnings growth of 17%. For investors looking beyond established giants, penny stocks—often representing smaller or newer companies—can offer intriguing opportunities. Although the term may seem outdated, these stocks remain relevant by providing potential growth when supported by robust financial health.

In the last week, the United States market has stayed flat despite being up 27% over the past year, with earnings forecasted to grow by 17% annually. In this environment, identifying stocks with strong growth potential and solid fundamentals can lead to uncovering hidden opportunities that may not yet be widely recognized.

Over the last 7 days, the United States market has remained flat, yet it has seen an impressive 27% increase over the past year with earnings projected to grow by 17% per annum in the coming years. In this context of robust growth expectations, dividend stocks that offer stability and consistent income can be attractive options for investors seeking to capitalize on these favorable conditions.

Even though Legence Corp. ( NASDAQ:LGN ) posted strong earnings, investors appeared to be underwhelmed. We did some...